ZTS Q2 2018 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.4B+11.5% YoY

Gross Profit

$945M66.8% margin

Operating Income

$484M34.2% margin

Net Income

$384M27.1% margin

EPS (Diluted)

$0.79

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$267M

Free Cash Flow

$194M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$8.6B

Total Liabilities

$6.6B

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.3B	+11.5%
Gross Profit	$945M	$807M	+17.1%
Operating Income	$484M	$383M	+26.4%
Net Income	$384M	$247M	+55.5%

Revenue Segments

Dogs and Cats

$630M45%

Cattle

$396M28%

Swine

$165M12%

Poultry

$129M9%

Horses

$41M3%

Fish

$24M2%

Sheep and Other

$20M1%

Geographic Segments

UNITED STATES

$677M69%

BRAZIL

$68M7%

CHINA

$60M6%

CANADA

$56M6%

GERMANY

$38M4%

SPAIN

$30M3%

FRANCE

$30M3%

ITALY

$26M3%